Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 648,488 shares at $42.01 ($18.2M) on 2021-11-16, disclosed to the SEC on 2021-11-18.
Open-market sale of $18.2M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 219,710 | $0 | 0.0% |
| 2 | $42.01 | 12,565 | $528K | 2.9% |
| 3 | $42.01 | 12,565 | $528K | 2.9% |
| 4 | $42.33 | 31,341 | $1.3M | 7.3% |
| 5 | $42.33 | 31,341 | $1.3M | 7.3% |
| 6 | $42.35 | 69,233 |
| $2.9M |
| 16.2% |
| 7 | $42.35 | 38,815 | $1.6M | 9.1% |
| 8 | $42.35 | 38,815 | $1.6M | 9.1% |
| 9 | $42.35 | 69,233 | $2.9M | 16.2% |
| 10 | $42.39 | 62,435 | $2.6M | 14.6% |
| 11 | $42.39 | 62,435 | $2.6M | 14.6% |
| Total | $27.99 avg | 648,488 | $18.2M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |